A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
IDEAYA Biosciences
IDEAYA Biosciences
National Institutes of Health Clinical Center (CC)
Azienda Ospedaliero-Universitaria di Parma
University of Nebraska
Medicenna Therapeutics, Inc.
Cancer Research UK